High Dropout Rate for Diabetes Medications Ozempic and Mounjaro
A study found that half of the patients using GLP-1 RAs, a class of injected drugs including Ozempic and Mounjaro, quit within a year due to gastrointestinal issues such as nausea, vomiting, and diarrhea. The discontinuation of these medications puts patients at a greater risk for hospitalizations related to diabetes. The study highlights the need for ongoing communication between patients and prescribers to address medication benefits, side effects, and costs.